These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11823154)

  • 1. Ask the Doctor: I know that most of the cholesterol-lowering statin drugs are supposed to be safe. But I am still shaken up by the news that one of these drugs, Baycol, caused several deaths due to muscle damage. If the rest of these drugs can also cause the same problem, how can any of them be considered safe?
    Harv Heart Lett; 2002 Jan; 12(5):8. PubMed ID: 11823154
    [No Abstract]   [Full Text] [Related]  

  • 2. By the way, doctor...I read about Baycol, the cholesterol-lowering drug being taken off the market because it caused fatal muscle damage. I don't take it, but I do take another statin. Should I be worried?
    Lee TH
    Harv Health Lett; 2001 Nov; 27(1):8. PubMed ID: 11724700
    [No Abstract]   [Full Text] [Related]  

  • 3. By the way, doctor... My doctor tells me that because I have diabetes and moderately high "bad" LDL cholesterol, I should be taking a statin. Is there any statin that's better than the rest? And what side effects should I be concerned about?
    Lee TH
    Harv Health Lett; 2001 Aug; 26(10):8. PubMed ID: 11546622
    [No Abstract]   [Full Text] [Related]  

  • 4. The pros and cons of statins. Cholesterol-lowering statin drugs won't make you heart attack-proof, but they do reduce your risk.
    Harv Mens Health Watch; 2013 Aug; 18(1):4. PubMed ID: 27024649
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-the-counter statin drug.
    Roberts WC
    Am J Cardiol; 2004 Nov; 94(10):1362. PubMed ID: 15541271
    [No Abstract]   [Full Text] [Related]  

  • 7. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Update of planning tables of cholesterol-lowering therapy orientated to achieve LDL therapeutic targets].
    Masana L; Plana N
    Clin Investig Arterioscler; 2015; 27(3):138-43. PubMed ID: 25865752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
    Hebert PR; Gaziano JM; Chan KS; Hennekens CH
    JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study shows link between high-dose statins and diabetes risk. But health experts caution that the cholesterol-lowering drugs are still a powerful and valuable ally against heart disease.
    Heart Advis; 2011 Sep; 14(9):6. PubMed ID: 27024250
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?
    Jacobson TA
    Mayo Clin Proc; 2006 Sep; 81(9):1225-31. PubMed ID: 16970219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving synergy and improvements in cholesterol lowering.
    Cardiovasc J S Afr; 2005; 16(1):63-4. PubMed ID: 15778782
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid control may require more than a statin. Additional medications or lifestyle changes may be necessary to lower total bad cholesterol and raise good cholesterol.
    Heart Advis; 2008 Nov; 11(11):6. PubMed ID: 19177684
    [No Abstract]   [Full Text] [Related]  

  • 18. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
    Hurley DL; Isley WL
    Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and the cholesterol mortality paradox.
    Nunes JP
    Scott Med J; 2017 Feb; 62(1):19-23. PubMed ID: 27889702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.